Giorgia Migliardi

Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens

Fiona M. Behan, Francesco Iorio, Gabriele Picco et al. · Nature · 2019 · 1.3K citations · Full text

Crispr–cas9 Screens, Gene Editing, Genome Editing +4

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi et al. · Cancer Discovery · 2011 · 938 citations · Full text

Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Alberto Bardelli, Simona Corso, Andrea Bertotti et al. · Cancer Discovery · 2013 · 654 citations · Full text

Engineering, Pathology, Cancer Biology +17

The genomic landscape of response to EGFR blockade in colorectal cancer

Andrea Bertotti, Eniko Papp, Siân Jones et al. · Nature · 2015 · 485 citations · Full text

Oncology, Genomic Landscape, Medicine +9

HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment

Shyam M. Kavuri, Naveen Jain, Francesco Galimi et al. · Cancer Discovery · 2015 · 286 citations · Full text